Solution Brief: Scalable Lab Adherence & Real-Time Safety Oversight for High Risk Therapies
Turn Complex Safety Monitoring Into a Competitive Advantage
Many specialty therapies require ongoing lab monitoring, safety oversight, and strict adherence protocols.
Monitoring processes that rely on manual coordination between providers, labs, and support programs result in provider frustration, missed collections, delayed safety alerts and reduced therapy adoption.
Leading pharmaceutical teams are solving this problem with RxPx’s result-driven lab monitoring infrastructure.
Download our latest Solution Brief to see how RxPx enables scalable lab adherence programs and real-time therapy safety monitoring.
1.2+ Million Labs Monitored to Date
RxPx supports pharmaceutical companies launching therapies that require coordinated lab monitoring, safety oversight, and adherence management.
Pharma Teams are Moving Toward Coordinated Monitoring Infrastructure
Rather than relying on fragmented workflows between labs, providers, and PSPs, leading organizations are implementing orchestrated safety monitoring programs that connect the entire care ecosystem enabling:
✓ Proactive monitoring instead of reactive follow-up
✓ Real-time visibility into patient adherence
✓ Automated detection of missed or abnormal lab results
✓ Reduced administrative burden for care teams
The result: improved provider confidence and stronger therapy adoption.
What You’ll Learn in this Solution Brief
Download and learn:
✓ How pharmaceutical companies operationalize lab monitoring programs at scale
✓ Infrastructure required for real-time therapy safety monitoring
✓ Strategies to improve lab adherence for specialty therapies
✓ How automated monitoring reduces provider burden and prescribing friction
✓ Real-world program outcomes across thousands of monitored labs
The Results
Discover How Scalable Safety Monitoring
Is a Competitive Advantage
Download our solution brief to learn how RxPx helps pharmaceutical companies implement automated lab monitoring programs
that support therapy adoption while protecting patients.